Alpha-2-macroglobulin and albumin are useful serum proteins to detect subclinical peritonitis in the rat

Peritoneal Dialysis International

Volumn 26, Issue 1, 2006, Pages 101-107

  van Westrhenen, Roos ^a   Westra, Wytske M ^a   van den Born, Jacob ^b   Kredie, Raymond T ^a   Keuning, Eelco D ^b   Hiralall, Johan ^a   Dragt, Cindy ^a   Hekking, Liesbeth H P ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Albumin; Alpha 2 macroglobulin; Chronic peritoneal exposure; Peritonitis; Rat model

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; DIANEAL; GLUCOSE; LACTIC ACID; PERITONEAL DIALYSIS FLUID; BIOLOGICAL MARKER; DIALYSIS FLUID; SERUM ALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PERITONITIS; CHRONIC TOXICITY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIALYSATE; DISEASE SEVERITY; DRUG EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; LEUKOCYTE COUNT; LONG TERM EXPOSURE; MALE; NONHUMAN; PERITONEAL DIALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; ANIMAL; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; HOSPITALIZATION; METABOLISM; PATHOLOGY; PERITONITIS; WISTAR RAT;

ALPHA-MACROGLOBULINS; ANIMALS; BIOLOGICAL MARKERS; DIALYSIS SOLUTIONS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; PERITONEAL DIALYSIS; PERITONITIS; RATS; RATS, WISTAR; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX;

EID: 33745483634     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600116     Document Type: Article

References (20)

1. Holmes CJ. Preclinical biocompatibility testing of peritoneal dialysis solutions. Perit Dial Int 2000; 20(Suppl 5): S5-9.
2. Beelen RH, Hekking LH, Zareie M, van den Born J. Rat models in peritoneal dialysis. Nephrol Dial Transplant 2001; 16:672-4.
3. ter Wee PM, Beelen RH, van den Born J. The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions. Kidney Int 2003; 64(Suppl 88):S75-83.
4. Lameire N, van Biesen W, van Landschoot M, Wang T, Heimburger O, Bergstrom J, et al. Experimental models in peritoneal dialysis: a European experience. Kidney Int 1998; 54:2194-206.
5. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallan M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
6. Margetts PJ, Kolb M, Yu L, Hoff CM, Gauldie J. A chronic inflammatory infusion model of peritoneal dialysis in rats. Perit Dial Int 2001; 21(Suppl 3):S368-72.
7. Zweers MM, Splint LJ, Krediet RT, Struijk D. Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat. Nephrol Dial Transplant 2001; 16:651-4.
8. Hekking LHP, Huijsmans A, Van Gelderop E, Wieslander AP, Havenith CE, van den Born J, et al. Effect of PD fluid in stillation on the peritonitis-induced influx and bacterial clearing capacity of peritoneal cells. Nephrol Dial Transplant 2001; 16:679-82.
9. Smorenburg SM, Griffini P, Tiggelman AB, Moorman AF, Boers W, Van Noorden JF. Alpha2-macroglobulin is mainly produced by cancer cells and not by hepatocytes in rats with colon carcinoma metastases in liver. Hepatology 1996; 23:560-70.
10. Hunter N, Weston KM, Bowern NA. Suppression of experimental allergic encephalomyelitis by α2M. Immunology 1991; 73:58-63.
11. Ninomiya M, Shimada M, Terashi T, Ijichi H, Yonemura V, Harada N, et al. Sustained spatial disturbance of bile canalicular networks during regeneration of the steatotic rat liver. Transplantation 2004; 77:373-9.
12. Mortier S, De Vriese AS, Leyssens A, Vanacker NJT, Faict D, Cornelissen M, et al. Antibiotic administration in an animal model of chronic peritoneal dialysate exposure. Perit Dial Int 2003; 23:331-8.
13. De Vriese AS, Mortier S, Cornelissen M, Palmans E, Vanacker NJ, Leyssens A, et al. The effects of heparin administration in an animal model of chronic peritoneal dialysis exposure. Perit Dial Int 2002, 22:566-72.
14. Sombolos K, Vas S, Rifkin O, Ayiomamitis A, McNamee P, Oreopoulos DG. Asymptomatic infection of the peritoneal effluent in CAPD patients. Nephrol Dial Transplant 1986; 1:114.
15. Douma CE, De Waart DR, Struijk DG, Krediet RT. Are phosphohpase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? J Lab Clin Med 1998; 132:329-40.
16. Zemel D, Koomen GCM, Hart NAM, Ten Berge RJM, Struijk DG, Krediet RT. Relationship of TNF-alpha, interleukin-6 and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993; 122:686-96.
17. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 35:644-52.
18. Giffen PS, Turton J, Andrews CM, Barret P, Clarke CJ, Fung KW, et al. Markers of experimental acute inflammation in the Wistar Han rat with particular reference to haptoglobin and C-reactive protein. Arch Toxicol 2003; 77:392-402.
19. Matic IS, Dinic S, Mihailovic M, Grigorov I, Bogolvic D, Poznanovic G. Acute-phase protein expression in DMSO-intoxicated rats. Toxicol Lett 2004; 147:153-9.
20. Calame W, Afram C, Blijleven N, Hendrikx RJ, Namavar F, Beelen RH. Establishing an experimental infection model for peritoneal dialysis: effect of inoculum and volume. Perit Dial Int 1993; 13(Suppl 2):S79-80.